Adderall 30mg tablets

Produkt Beschreibung

Adderall 30 mg represents the maximum single-unit immediate-release therapeutic dose of mixed amphetamine salts approved for clinical use. In international forensic casework and domestic illicit supply chain surveillance (frequently cataloged under illicit bulk distribution headers such as “100x–1000x Pharma-Grade 30mg Adderall US 2 US”), this specific dose unit represents one of the most widely counterfeited solid-dose pharmaceuticals in circulation. While legitimate pharmaceutical manufacturing produces an exact stoichiometric mixture of four specific amphetamine salts, forensic analyses by the DEA, FDA, and independent drug-checking services indicate that illicit marketplace exhibits claiming to be “diverted pharma-grade” 30 mg Adderall are overwhelmingly clandestine pressed tablets composed of illicitly synthesized methamphetamine hydrochloride, caffeine, and inert binders.

Pharmaceutical Composition & Stereoisomeric Ratio

• Active Pharmaceutical Ingredients (Legitimate Formulation): 30 mg total mixed amphetamine salts formulated in a strict 3:1 ratio of dextro- ($\text{d-}$) to levo- ($\text{l-}$) optical isomers:

  • Dextroamphetamine Saccharate: 7.5 mg

  • Amphetamine Aspartate Monohydrate: 7.5 mg

  • Dextroamphetamine Sulfate, USP: 7.5 mg

  • Amphetamine Sulfate, USP: 7.5 mg

• Net Base Equivalence: Delivers 18.75 mg of active amphetamine base (14.06 mg active $\text{d-amphetamine}$ base and 4.69 mg active $\text{l-amphetamine}$ base).

• Physical Architecture (Authentic Formulations):

  • Teva/Barr Generic Reference: Round, peach/orange biconvex tablet debossed with “b 974” on the obverse and “3 | 0” across a deep quad-score or bisecting score on the reverse.

  • CorePharma Generic Reference: Oval/round peach tablet debossed with “dp” on the obverse and “30” on the reverse.

  • Excipients: Microcrystalline cellulose, colloidal silicon dioxide, compressible sugar, cornstarch, magnesium stearate, and FD&C Yellow #6 aluminum lake (providing the characteristic peach/orange hue).

Pharmacodynamics & Stereoisomer Mechanisms

• Intracellular Target Modulation (TAAR1 & VMAT2): Amphetamine enters presynaptic monoaminergic neurons via passive lipophilic diffusion and carrier-mediated transport. Intracellularly, it acts as an agonist at the trace amine-associated receptor 1 ($\text{TAAR1}$) and competitively inhibits the vesicular monoamine transporter 2 ($\text{VMAT}_2$), collapsing the proton gradient and promoting the leakage of neurotransmitters from storage vesicles into the cytoplasm.

• Transporter Reversal: Phosphorylation mediated through $\text{TAAR1}$ cascades triggers the functional reversal of the dopamine transporter ($\text{DAT}$) and norepinephrine transporter ($\text{NET}$), producing non-exocytotic efflux of dopamine and norepinephrine into the synaptic cleft.

• Isomeric Functional Differentiation:

  • $d$-Amphetamine: Displays 3- to 4-fold higher central dopaminergic and noradrenergic activity relative to its enantiomer, mediating primary therapeutic improvements in executive function, sustained attention, and impulse control, as well as high central reinforcement and addiction liability.

  • $l$-Amphetamine: Displays weaker central dopaminergic affinity but significantly higher potency at peripheral $\alpha$– and $\beta$-adrenergic receptors, modulating cardiovascular tone, peripheral vasoconstriction, elevated mean arterial pressure, and sustaining extended wakefulness.

Clandestine Counterfeiting & Illicit Market Reality

• The “Pharma-Grade” Façade: Bulk commercial listings on unverified digital channels advertising “pharma-grade” or “pharmacy-diverted” 30 mg tablets are predominantly produced in clandestine rotary press labs:

  • Methamphetamine Substitution: The vast majority of counterfeit “b 974” or “dp 30” tablets analyzed by forensic laboratories contain illicit racemic or $\text{d-methamphetamine hydrochloride}$ rather than mixed amphetamine salts, as methamphetamine is less expensive and more readily synthesized at industrial scale in clandestine networks.

  • Dosage Variability: Quantified active loads in pressed counterfeits vary wildly (from 5 mg to over 60 mg of active methamphetamine salt per tablet), creating substantial risk of acute stimulant poisoning.

  • Cross-Contamination Hazards: Clandestine tableting environments regularly handle synthetic opioids; multiple public health alerts have documented counterfeit Adderall tablets contaminated with trace or lethal quantities of fentanyl.

Analytical Screening & Forensic Differentiation

• Presumptive Colorimetric Spot Testing (Differentiating Authentic vs. Counterfeit):

  • Marquis Reagent: Authentic amphetamine yields an immediate transition from clear to strong orange-red/reddish-brown. (Note: Methamphetamine yields a near-identical orange-brown response, making Marquis insufficient to detect counterfeit substitution).

  • Simon’s Reagent (The Definitive Field Discriminator):

    • Authentic Adderall (Primary Amine): Negative (no color change; remains clear or pale).

    • Counterfeit Methamphetamine Press (Secondary Amine): Immediate vivid cobalt blue. This provides a rapid, high-confidence field identification of a counterfeit tablet substituted with methamphetamine.

• Instrumental Profiling & Mass Spectrometry:

  • Gas Chromatography-Mass Spectrometry (GC-MS, EI): Authentic amphetamine exhibits a primary diagnostic base peak at $m/z$ 44 ($[\text{CH}_3\text{CH}=\text{NH}_2]^+$), corresponding to $\alpha$-cleavage of the ethylamine side chain, with secondary ions at $m/z$ 91 (tropylium ion) and $m/z$ 65. If the exhibit is counterfeit methamphetamine, the mass spectrum shifts to a diagnostic base peak at $m/z$ 58 ($[\text{CH}_3\text{CH}=\text{NHCH}_3]^+$).

  • Chiral Chromatography: Utilized to verify the precise 3:1 enantiomeric ratio of $\text{d-}$ to $\text{l-amphetamine}$, distinguishing authentic pharmaceutical product from diverted illicit speed (racemic 1:1 dl-amphetamine).

Regulatory Classification & Institutional Governance

• Controlled Substance Classification: Genuine mixed amphetamine salts are classified as Schedule II controlled substances under the United States Controlled Substances Act (high abuse potential, severe psychological or physical dependence liability, with recognized clinical uses). Classified as a Class B controlled drug in the United Kingdom under the Misuse of Drugs Act 1971.

• Handling & Compliance Mandates: Distribution and procurement of pharmaceutical standards or forensic testing samples require registered DEA Schedule II licenses, double-lock physical vault storage, active quota allocation, and strict chain-of-custody documentation.

Weitere Informationen